Showing results (11-20 of 850) with videos related to

Sort By:
Pageof 85
British Journal of Haematology|July 9, 2003
Bone marrow angiogenesis and circulating plasma cells in multiple myelomaShaji Kumar, Thomas E Witzig, Philip R Greipp, et al.
Leukemia Research|October 6, 2014
Multiple mechanisms contribute to the synergistic anti-myeloma activity of the pan-histone deacetylase inhibitor LBH589 and the rapalog RAD001Vijay Ramakrishnan, Teresa Kimlinger, Michael Timm, et al.
Haematologica|July 28, 2006
Differential expression of vascular endothelial growth factors and their receptors in multiple myelomaTeresa Kimlinger, Michael Kline, Shaji Kumar, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM)Robert A Kyle, Angela Dispenzieri, Shaji Kumar, et al.
Blood Cancer Journal|February 16, 2023
Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significanceAlexander J Ryu, Shaji Kumar, Angela Dispenzieri, et al.
Plos One|November 28, 2012
Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathwayVijay Ramakrishnan, Teresa Kimlinger, Jessica Haug, et al.
American Journal of Hematology|March 18, 2021
Use of endpoints in multiple myeloma randomized controlled trials over the last 15 years: A systematic reviewGhulam Rehman Mohyuddin, Kelly Koehn, Al-Ola Abdallah, et al.
Blood Cancer Journal|May 25, 2026
Prevalence of monoclonal gammopathy of undetermined significance (MGUS) using a sensitive mass spectrometry assay in young individuals 10-49 years of age: a population-based study from the National Health and Nutritional Examination SurveyShaji Kumar, David Murray, Dirk R Larson, et al.
Blood Cancer Journal|February 10, 2021
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)Li Pang, S Vincent Rajkumar, Prashant Kapoor, et al.
The New England Journal of Medicine|January 18, 2018
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined SignificanceRobert A Kyle, Dirk R Larson, Terry M Therneau, et al.
Pageof 85